[ASND] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
27-Apr-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 46.53%
YoY- 11.62%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 137,702 48,034 47,393 33,589 22,896 15,290 6,160 689.06%
PBT -81,088 -161,578 -121,862 -109,617 -202,069 -169,122 -81,366 -0.22%
Tax 5,790 645 -429 1,297 5,349 -167 -47 -
NP -86,878 -162,223 -121,433 -110,914 -207,418 -168,955 -81,319 4.49%
Tax Rate - - - - - - - -
Total Cost 224,580 210,257 168,826 144,503 230,314 184,245 87,479 87.16%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -63.09 -337.73 -256.23 -330.21 -905.91 -1,105.00 -1,320.11 -86.75%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -1.53 -2.88 -2.16 -1.98 -3.70 -3.03 -1.46 3.16%
EPS Diluted -1.53 -2.88 -2.16 -1.98 -3.70 -3.03 -1.46 3.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.